July 2026 There is growing interest in reusing water for potable and non-potable applications exemplified by the U.S. Environmental Protection Agency (EPA)’s Water… read more
ToxStrategies LLC, a BlueRidge Life Sciences (BRLS) company, is pleased to announce that Ming Kung, PhD, DABT, has joined the company as President,… read more
ToxStrategies will present at The Society of Environmental Toxicology and Chemistry’s (SETAC’s) 36th Annual European Meeting, May 17–21, 2026, in Maastricht, The Netherlands…. read more
ToxStrategies scientists will be attending and presenting at the SOT 65th Annual Meeting and ToxExpo in San Diego, CA, March 23-25, 2026. Please… read more
We are pleased to announce that Dr. David W. Eaker, Ph.D., DABT, recently joined ToxStrategies as a Senior Consultant in our Pharmaceutical practice…. read more
Dr. Naomi Sacks, BRLS Vice President in our Pharmaceutical Commercialization practice, is a co-author of a study recently published in JAC-Antimicrobial Research. Dr…. read more
We are pleased to announce that Amanda Burns, MSPH, DABT, recently joined ToxStrategies as a Principal Scientist in our Causation Analysis practice. Amanda… read more
ToxStrategies scientists are participating in the Society of Environmental Toxicology and Chemistry (SETAC)’s North America 46th Annual Meeting next week, November 16 through… read more
ToxStrategies, a BlueRidge Life Sciences Company, is looking forward to presenting our poster on “Using IVIVE to address systemic exposure challenges in genotoxicity… read more
ToxStrategies scientists William Rish, LeeAnn Racz, and Alan Hale have published a new study examining potential radiation exposure from using wastewater from conventional… read more
